Hoveyda; Hamid R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hoveyda; Hamid R..The latest application filed is for "novel n-acyl-[3-substituted]-[8-substituted]-5,6-dihydro-[1,2,4]triazolo[4- ,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders".

Company Profile

13.31.39

Hoveyda; Hamid R. - Brussels BE
Hoveyda; Hamid R. - Bruxelles BE
Hoveyda; Hamid R. - Quebec CA
Hoveyda; Hamid R. - Sherbrooke CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 11,072,582 - Hoveyda , et al. July 27, 2	2021-07-27
NOVEL N-ACYL-[3-SUBSTITUTED]-[8-SUBSTITUTED]-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4- ,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS App 20210094959 - Hoveyda; Hamid R. ; et al.	2021-04-01
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazi- nes as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 10,941,151 - Hoveyda , et al. March 9, 2	2021-03-09
Substituted Pyrrolidines As G-protein Coupled Receptor 43 Agonists App 20200347016 - Hoveyda; Hamid R. ; et al.	2020-11-05
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 10,781,171 - Hoveyda , et al. Sept	2020-09-22
Novel Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines As Selective Nk-3 Receptor Antagonists, Phar App 20200283447 - Hoveyda; Hamid R. ; et al.	2020-09-10
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazi- nes as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 10,683,295 - Hoveyda , et al.	2020-06-16
Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Di App 20200148636 - Hoveyda; Hamid R. ; et al.	2020-05-14
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Di App 20200125564 - Hoveyda; Hamid R. ; et al.	2020-04-23
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 10,577,318 - Hoveyda , et al.	2020-03-03
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 10,544,150 - Hoveyda , et al. Ja	2020-01-28
Substituted Pyrrolidines As G-protein Coupled Receptor 43 Agonists App 20190300478 - Hoveyda; Hamid R. ; et al.	2019-10-03
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 10,358,416 - Hoveyda , et al. July 23, 2	2019-07-23
Novel Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines As Selective Nk-3 Receptor Antagonists, Pharmaceutical Composition, Methods For Use In Nk-3 Receptor Mediated Disorders And Chiral Synthesis Thereof App 20190023711 - Hoveyda; Hamid R. ; et al.	2019-01-24
Substituted Pyrrolidines As G-protein Coupled Receptor 43 Agonists App 20180297944 - Hoveyda; Hamid R. ; et al.	2018-10-18
Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyraz- ines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 10,065,961 - Hoveyda , et al. September 4, 2	2018-09-04
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 10,065,960 - Hoveyda , et al. September 4, 2	2018-09-04
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20180194772 - Hoveyda; Hamid R. ; et al.	2018-07-12
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 10,017,468 - Hoveyda , et al. July 10, 2	2018-07-10
Macrocyclic Modulators of the Ghrelin Receptor App 20180110824 - Hoveyda; Hamid R. ; et al.	2018-04-26
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 9,926,325 - Hoveyda , et al. March 27, 2	2018-03-27
Substituted Pyrrolidines As G-protein Coupled Receptor 43 Agonists App 20170283376 - Hoveyda; Hamid R. ; et al.	2017-10-05
Substituted pyrrolidines as G-protein coupled receptor 43 agonists Grant 9,695,120 - Hoveyda , et al. July 4, 2	2017-07-04
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazi- nes as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 9,475,814 - Hoveyda , et al. October 25, 2	2016-10-25
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20150315199 - Hoveyda; Hamid R. ; et al.	2015-11-05
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20140371218 - Hoveyda; Hamid R. ; et al.	2014-12-18
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 8,871,761 - Hoveyda , et al. October 28, 2	2014-10-28
NOVEL CHIRAL N-ACYL-5,6,7(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF App 20140275097 - Hoveyda; Hamid R. ; et al.	2014-09-18
Spatially-defined macrocycles incorporating peptide bond surrogates Grant 8,557,765 - Deslongchamps , et al. October 15, 2	2013-10-15
Processes for intermediates for macrocyclic compounds Grant 8,497,242 - Marsault , et al. July 30, 2	2013-07-30
Methods of using macrocyclic modulators of the ghrelin receptor Grant 8,450,268 - Fraser , et al. May 28, 2	2013-05-28
Spatially-defined macrocyclic compounds useful for drug discovery Grant 8,440,851 - Marsault , et al. May 14, 2	2013-05-14
Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disorders As Agonists Of G-protein Coupled Receptor 43 (gpr43) App 20130023539 - Hoveyda; Hamid R. ; et al.	2013-01-24
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20130023530 - Hoveyda; Hamid R. ; et al.	2013-01-24
Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor Grant 8,349,887 - Fraser , et al. January 8, 2	2013-01-08
Processes For Intermediates For Macrocyclic Compounds App 20120226067 - Marsault; Eric ; et al.	2012-09-06
Processes For Intermediates For Macrocyclic Compounds App 20120226072 - Marsault; Eric ; et al.	2012-09-06
Processes For Intermediates For Macrocyclic Compounds App 20120226066 - Marsault; Eric ; et al.	2012-09-06
Processes For Intermediates For Macrocyclic Compounds App 20120165566 - Marsault; Eric ; et al.	2012-06-28
Methods Of Using Macrocyclic Agonists Of The Ghrelin Receptor For Treatment Of Gastrointestinal Motility Disorders App 20120071412 - Fraser; Graeme L. ; et al.	2012-03-22
Processes for intermediates for macrocyclic compounds Grant 8,129,561 - Marsault , et al. March 6, 2	2012-03-06
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders Grant 8,088,733 - Fraser , et al. January 3, 2	2012-01-03
Methods Of Using Macrocyclic Modulators Of The Ghrelin Receptor App 20110288163 - Fraser; Graeme L. ; et al.	2011-11-24
Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same App 20110245159 - Hoveyda; Hamid R. ; et al.	2011-10-06
Processes for Intermediates for Macrocyclic Compounds App 20110245459 - Marsault; Eric ; et al.	2011-10-06
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery App 20110237785 - Marsault; Eric ; et al.	2011-09-29
Spatially-defined macrocyclic compounds useful for drug discovery Grant 8,022,252 - Deslongchamps , et al. September 20, 2	2011-09-20
Methods of using macrocyclic modulators of the ghrelin receptor Grant RE42,624 - Fraser , et al. August 16, 2	2011-08-16
Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same App 20110105389 - Hoveyda; Hamid R. ; et al.	2011-05-05
Spatially-defined Macrocycles Incorporating Peptide Bond Surrogates App 20090312540 - Deslongchamps; Pierre ; et al.	2009-12-17
Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same App 20090275648 - Fraser; Graeme L. ; et al.	2009-11-05
Intermediates For Macrocyclic Compounds App 20090240027 - Marsault; Eric ; et al.	2009-09-24
Macrocyclic Modulators of the Ghrelin Receptor App 20090198050 - Marsault; Eric ; et al.	2009-08-06
Methods Of Using Macrocyclic Modulators Of The Ghrelin Receptor App 20090170757 - Fraser; Graeme L. ; et al.	2009-07-02
Spatially-defined macrocycles incorporating peptide bond surrogates Grant 7,550,431 - Deslongchamps , et al. June 23, 2	2009-06-23
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery App 20090137817 - Deslongchamps; Pierre ; et al.	2009-05-28
Processes For Intermediates For Macrocyclic Compounds App 20090137835 - Marsault; Eric ; et al.	2009-05-28
Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity App 20090054451 - Huck; Jacques ; et al.	2009-02-26
Novel Piperidine-4-Acetic Acid Derivatives and Their Use App 20090048291 - Huck; Jacques ; et al.	2009-02-19
Methods of using macrocyclic modulators of the ghrelin receptor Grant 7,491,695 - Fraser , et al. February 17, 2	2009-02-17
Macrocyclic modulators of the ghrelin receptor Grant 7,476,653 - Hoveyda , et al. January 13, 2	2009-01-13
Methods Of Using Macrocyclic Agonists Of The Ghrelin Receptor For Treatment Of Gastrointestinal Motility Disorders App 20080051383 - Fraser; Graeme L. ; et al.	2008-02-28
Methods of using macrocyclic modulators of the ghrelin receptor App 20070021331 - Fraser; Graeme L. ; et al.	2007-01-25
Macrocyclic modulators of the ghrelin receptor App 20060025566 - Hoveyda; Hamid R. ; et al.	2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.